The monoclonal antibody 2G2 has been used extensively for detection and quantification of structural changes of human rhinovirus serotype 2 during infection. It recognizes exclusively A and B subviral particles, not native virus. We have elucidated the basis of this selectivity by determining the footprint of 2G2. Since viral escape mutants obviously cannot be obtained, the structures of complexes between Fab fragments of 2G2 and 80S subviral B particles were determined by cryoelectron microscopy. The footprint of the antibody corresponds to the capsid region that we predicted would undergo the most dramatic changes upon RNA release.Human rhinoviruses (HRVs) belong to the picornavirus family. They are icosahedral with Tϭ1, pseudo-Tϭ3 symmetry, are about 30 nm in diameter, and are composed of 60 copies of each of the proteins VP1 through VP4 that encapsidate a single-stranded positive-sense RNA genome. Twelve of the 99 serotypes, the minor receptor group, bind members of the low-density lipoprotein receptor family for cell entry, whereas the remaining 87 serotypes use intercellular adhesion molecule 1 (ICAM-1) for infection.As shown for the major group virus HRV serotype 14 (HRV14) and for the minor group virus HRV2, receptor binding is followed by internalization via the clathrin-mediated endocytic pathway (8,25). Within the endosome, the virion undergoes coordinated structural changes preceding the RNA release into the cytosol. For major group viruses, these changes are catalyzed by the ICAM-1 receptor and possibly aided by low endosomal pH (22). In the case of minor group viruses, the low pH of the late endosomal compartment is the exclusive trigger for these modifications.HRV2 has been extensively analyzed with respect to these structural changes (9, 11, 12, 14-17, 20, 21). In the first step, the innermost capsid protein VP4 is released, giving rise to subviral particles sedimenting at about 135S, whereas the native virion sediments at 150S. This change in sedimentation behavior is accompanied by changes in antigenicity. The RNA is then released, resulting in an empty capsid with a sedimentation constant of 80S that is finally degraded in lysosomes (24). Using cryoelectron microscopy (cryo-EM) and X-ray structural data, we produced a model for the HRV2 empty capsid after RNA release (9). The capsid was seen to have expanded by 4%, with a relative movement of all capsid proteins. In particular, the viral protein VP1 around the fivefold axes make an iris type of movement to open a 10-Å-diameter channel, which allows the RNA genome to exit.The monoclonal antibody 2G2, obtained from a mouse injected with purified HRV2, proved extremely useful for the detection of the structural changes occurring upon infection. For example, it was employed to unequivocally demonstrate the low-pH dependency of HRV2 for infection; no subviral particles were formed in the presence of inhibitors of endosomal acidification, such as monensin (18) or the H ϩ -ATPasespecific drug bafilomycin A1 (2, 3, 5, 23). However, although the antibo...